Table 2.
Univariate and multivariate analysis of overall survival
| Clinical parameters | Univariate analysis
|
Multivariate analysis
|
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age | 0.781 (0.472–1.291) | 0.816 | ||
| Gender | 0.932 (1.351–4.774) | 0.055 | ||
| Smoking | 1.047 (0.710–1.546) | 0.335 | ||
| Differentiation | 1.080 (0.695–1.680) | 0.731 | ||
| EGFR gene mutation | 0.666 (0.411–1.081) | 0.200 | ||
| Lymph node metastasis | 1.907 (1.136–5.398) | 0.023 | ||
| Tumor size | 0.581 (0.294–1.065) | 0.077 | ||
| TNM stage | 2.292 (1.498–3.331) | 0.000 | 2.077 (1.389–3.141) | 0.000 |
| B7-H3 expression | 3.167 (1.616–6.327) | 0.001 | 3.187 (1.601–6.310) | 0.000 |
Abbreviation: HR, hazard ratio.